Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 10, 2009, Pages 1265-1270

  Qazilbash, Muzaffar H ^a   Amjad, Ali Imran ^b   Qureshi, Suhail ^a   Qureshi, Sofia R ^a   Saliba, Rima M ^a   Khan, Ziad U ^c   Hosing, Chitra ^a   Giralt, Sergio A ^a   De Lima, Marcos J ^a   Popat, Uday R ^a   Yusuf, Syed W ^a   Champlin, Richard E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Low ejection fraction

Indexed keywords

CYCLOPHOSPHAMIDE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 69749125487     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.06.001     Document Type: Article

References (25)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
2. Bearman S.I., Petersen F.B., Schor R.A., et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 5 (1990) 173-177
3. Fujimaki K., Maruta A., Yoshida M., et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 27 (2001) 307-310
4. Sakata-Yanagimoto M., Kanda Y., Nakagawa M., et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant 33 (2004) 1043-1047
5. Tichelli A., Bhatia S., and Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 142 (2008) 11-26
6. Yoshimi A., Nannya Y., Sakata-Yanagimoto M., et al. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation. Am J Hematol 83 (2008) 635-639
7. Gopal A.S., Shen Z., Sapin P.M., et al. Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. Circulation 92 (1995) 842-853
8. Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAE v3.0). DCTD, NCI, NIH, DHHS, 2006.
9. Akahori M., Nakamae H., Hino M., et al. Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue. Bone Marrow Transplant 31 (2003) 585-590
10. Zangari M., Henzlova M.J., Ahmad S., et al. Predictive value of left ventricular ejection fraction in stem cell transplantation. Bone Marrow Transplant 23 (1999) 917-920
11. Cazin B., Gorin N.C., Laporte J.P., et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 57 (1986) 2061-2069
12. Hertenstein B., Stefanic M., Schmeiser T., et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 12 (1994) 998-1004
13. Kupari M., Volin L., Suokas A., Timonen T., Hekali P., and Ruutu T. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 5 (1990) 91-98
14. Murdych T., and Weisdorf D.J. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 28 (2001) 283-287
15. Sucak G.T., Ozkurt Z.N., Aki Z., Yagci M., Cengel A., and Haznedar R. Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity. Transplant Proc 40 (2008) 1586-1590
16. Buja L.M., Ferrans V.J., and Graw Jr. R.G. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 7 (1976) 17-45
17. Trigg M.E., Finlay J.L., Bozdech M., and Gilbert E. Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation. Cancer 59 (1987) 38-42
18. Baello E.B., Ensberg M.E., Ferguson D.W., et al. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep 70 (1986) 1187-1193
19. Benoff L.J., and Schweitzer P. Radiation therapy-induced cardiac injury. Am Heart J 129 (1995) 1193-1196
20. Braverman A.C., Antin J.H., Plappert M.T., Cook E.F., and Lee R.T. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 9 (1991) 1215-1223
21. Coghlan J.G., Handler C.E., and Kottaridis P.D. Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 20 (2007) 247-263
22. Lopez-Jimenez J., Cervero C., Munoz A., et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 13 (1994) 789-793
23. Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 125 (1996) 47-58
24. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110 (2007) 4606-4613
25. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919